USA Moderna’s COVID-19 Vaccine Candidate Meets Primary Efficacy Endpoint in First Interim Analysis of Phase 3 COVE Study
USA Aftermath Services and Lincolnshire Management Pivot to Unlock the Strategic Value of Deep Cleaning